Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Back in January we explained how many pharmaceutical companies, following a Hollywood business model, have started to experience an erosion of their profits as patents expire on their “blockbuster” drugs. Aggressive, multi-billion-dollar marketing campaigns lead to multi-billion-dollar drug sales, but when patents expire, so do profits.

Read the rest of this entry »

The Los Angeles Times on Sunday examined how the business “strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth” might have begun to “betray it.”

Read the rest of this entry »